Nifty Pharma
A Healthy Choice for Capturing Growth in the Indian Pharmaceutical Industry
As of Jun 19, 2026, the PE ratio is 37.38 and the PB ratio is 5.14
Index Report
Easy-to-read, rules-based summary. Educational only.
1) Index Snapshot (1-minute read)
Nifty Pharma is at 24,460.30 as of Jun 19, 2026. 1Y CAGR is 13.65%. It is 1.73% below its recent peak. Current valuation: PE 37.38, PB 5.14.
2) Valuation Zone
Zone is Expensive based on the last 15Y of PE/PB history.
3) Earnings Growth Health
Composite proxy: -5.47% (weighted 1Y/3Y/5Y/10Y/15Y).
Status map: 1Y Weak.
Proxy = price CAGR minus PE CAGR. Overall trend uses weighted proxy across 1Y/3Y/5Y/10Y/15Y, so single-year noise has less impact.
4) Sector Contribution Breakdown
Based on constituent counts (weights not available).
5) Risk Signals
- Volatility is low (14.19%). Moves are calmer.
- Index is near its recent peak (drawdown 1.73%).
- Valuation is elevated vs history.
Signals are descriptive, not predictions.
6) Action Guidance
Maintain SIP contributions for long-term discipline.
Avoid lump-sum entries at elevated valuations.
Rules-based guidance for long-term investors. Not a buy/sell call.
7) Index vs Inflation vs FD
Inflation and FD rates are not configured yet.
Supporting Guides
Intent-focused pages connected to this index.
- Nifty Pharma PE Ratio: Current and Historical Context
Current PE ratio, long-term averages, and valuation percentile for Nifty Pharma.
- Nifty Pharma PB Ratio: Current and Historical Context
Current PB ratio, long-term averages, and valuation percentile for Nifty Pharma.
- Nifty Pharma Dividend Yield: Current Yield and Trend
Current dividend yield and historical yield context for Nifty Pharma.
- Nifty Pharma Returns: Historical Performance
Historical return windows, drawdown, and volatility for Nifty Pharma.
- Nifty Pharma Constituents and Sector Mix
Companies, industries, and sector exposure available for Nifty Pharma.
- Nifty Pharma ETF List and Comparison
ETF trackers and available expense data for Nifty Pharma.
- Nifty Pharma Valuation: Cheap, Fair, or Expensive?
A data-driven valuation view for Nifty Pharma using current and historical index metrics.
Technical Signals
Historical vs. Current Market
Compare its historical behavior with the current market environment to gain insights into potential trends.
| Greedy | Fear | Current Market Jun 19, 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PE | PB | DIV | Points | PE | PB | DIV | Points | Fall(%) | ~ | PE | PB | DIV | MRI Level |
| Jan 16, 2020 | Mar 24, 2020 | ~ | 37.38 | 5.14 | 0.75 | ||||||||
| 26.32 | 3.23 | 0.63 | 8203.10 | 20.42 | 2.53 | 0.82 | 6611.05 | -19.41 | 42.02 83.06 | 59.13 103.16 | 19.05 8.54 | 25 | |
| Apr 09, 2015 | Mar 24, 2020 | ||||||||||||
| 55.80 | 9.33 | 0.48 | 13545.90 | 20.42 | 2.53 | 0.82 | 6611.05 | -51.2 | 33.01 83.06 | 44.91 103.16 | 56.25 8.54 | 25 | |
Recent Performance
Analyze the recent performance of the Nifty Pharma, including its recent highs and lows
| Recent High | Recent Low | Current Market Jun 19, 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PE | PB | DIV | Points | PE | PB | DIV | Points | Fall(%) | ~ | PE | PB | DIV | Points |
| May 21, 2026 | Jun 02, 2026 | ~ | Jun 19, 2026 | ||||||||||
| 38.93 | 5.42 | 0.63 | 24890.90 | 36.69 | 5.22 | 0.68 | 24006.30 | -3.55 | 37.38 | 5.14 | 0.75 | 24460.30 (1.89% ) | |
Performance
Past performance returns (%) of the index
| # | 1D | 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y | 15Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nifty Pharma | 0.73 | 0.63 | 1.45 | 8.24 | 6.78 | 11.45 | - | - | - | - | - |
Fundamentals
Nifty Pharma
| PE | PB | Div |
|---|---|---|
| 37.38 | 5.14 | 0.75 |
Exchange Traded Funds (ETF)
Available ETFs tracking this index
Exchange Trade Fund ( ETF )
| Name of the ETF | Expense |
|---|---|
| Nippon India Nifty Pharma ETF | 0.21 |
Index Companies
Companies included in this index
Companies
| Name of the company | Industry | Symbol |
|---|---|---|
| Abbott India Ltd. | Healthcare | ABBOTINDIA |
| Alembic Pharmaceuticals Ltd. | Healthcare | APLLTD |
| Alkem Laboratories Ltd. | Healthcare | ALKEM |
| Aurobindo Pharma Ltd. | Healthcare | AUROPHARMA |
| Biocon Ltd. | Healthcare | BIOCON |
| Cipla Ltd. | Healthcare | CIPLA |
| Divi's Laboratories Ltd. | Healthcare | DIVISLAB |
| Dr. Reddy's Laboratories Ltd. | Healthcare | DRREDDY |
| Gland Pharma Ltd. | Healthcare | GLAND |
| Glenmark Pharmaceuticals Ltd. | Healthcare | GLENMARK |
| Granules India Ltd. | Healthcare | GRANULES |
| Ipca Laboratories Ltd. | Healthcare | IPCALAB |
| Laurus Labs Ltd. | Healthcare | LAURUSLABS |
| Lupin Ltd. | Healthcare | LUPIN |
| NATCO Pharma Ltd. | Healthcare | NATCOPHARM |
| Pfizer Ltd. | Healthcare | PFIZER |
| Strides Pharma Science Ltd. | Healthcare | STAR |
| Sun Pharmaceutical Industries Ltd. | Healthcare | SUNPHARMA |
| Torrent Pharmaceuticals Ltd. | Healthcare | TORNTPHARM |
| Zydus Lifesciences Ltd. | Healthcare | ZYDUSLIFE |